scholarly article | Q13442814 |
P2093 | author name string | Gilli P | |
Catalano C | |||
Di Landro D | |||
Bordin V | |||
Fabbian F | |||
Cavagna R | |||
Lambertini D | |||
Squerzanti R | |||
Tarroni G | |||
P433 | issue | 3 | |
P921 | main subject | Atrial Fibrillation | Q815819 |
P1104 | number of pages | 6 | |
P304 | page(s) | 234-239 | |
P577 | publication date | 2000-09-01 | |
P1433 | published in | Clinical Nephrology | Q15763520 |
P1476 | title | Clinical characteristics associated to atrial fibrillation in chronic hemodialysis patients. | |
P478 | volume | 54 |
Q91588373 | Association Between Use of Warfarin for Atrial Fibrillation and Outcomes Among Patients With End-Stage Renal Disease: A Systematic Review and Meta-analysis |
Q37496206 | Atrial Fibrillation and Oral Anticoagulation in Chronic Kidney Disease |
Q24798420 | Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality |
Q37495851 | Chronic Kidney Disease and Atrial Fibrillation: A Contemporary Overview |
Q33940481 | Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC). |
Q37165278 | Cigarette smoking: an important renal risk factor - far beyond carcinogenesis |
Q46661747 | Cigarette smoking: an important renal risk factor – far beyond carcinogenesis. |
Q47097687 | Comparison of the CHADS2, CHA2DS2-VASc and R2CHADS2 Scores in Japanese Patients with Non-valvular Paroxysmal Atrial Fibrillation Not Receiving Anticoagulation Therapy |
Q35040302 | Estimated glomerular filtration rate and proteinuria are separately and independently associated with the prevalence of atrial fibrillation in general population |
Q35026672 | Incidence of thromboembolic stroke and of major bleeding in patients with atrial fibrillation and chronic kidney disease treated with and without warfarin. |
Q44734027 | Increased P wave dispersion and maximum P wave duration after hemodialysis. |
Q37205144 | Increased risk of atrial fibrillation in end-stage renal disease patients on dialysis: A nationwide, population-based study in Taiwan |
Q37454324 | Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: results from the DOPPS |
Q37469045 | Management of Atrial Fibrillation in Patients With Kidney Disease |
Q36009279 | Prediction of Mortality in Incident Hemodialysis Patients: A Validation and Comparison of CHADS2, CHA2DS2, and CCI Scores |
Q33684173 | Prevalence of atrial fibrillation and its predictors in nondialysis patients with chronic kidney disease |
Q61850990 | Primary prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with end-stage renal disease undergoing dialysis |
Q92447909 | Stroke Prophylaxis in Patients with Atrial Fibrillation and End-Stage Renal Disease |
Q34534916 | The increasing prevalence of atrial fibrillation among hemodialysis patients |
Q52901309 | The occurrence of atrial fibrillation in dialysis patients and its association with left atrium volume before and after dialysis. |
Q37477826 | The prevalence of and factors associated with chronic atrial fibrillation in Medicare/Medicaid-eligible dialysis patients |
Q34938763 | Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty |
Search more.